Conformational diversity and ligand tunnels of mammalian cytochrome P450s
暂无分享,去创建一个
[1] C David Stout,et al. Structure of a substrate complex of mammalian cytochrome P450 2C5 at 2.3 A resolution: evidence for multiple substrate binding modes. , 2003, Biochemistry.
[2] J. Halpert,et al. Structures of cytochrome P450 2B4 complexed with the antiplatelet drugs ticlopidine and clopidogrel . , 2010, Biochemistry.
[3] C David Stout,et al. Adaptations for the Oxidation of Polycyclic Aromatic Hydrocarbons Exhibited by the Structure of Human P450 1A2*♦ , 2007, Journal of Biological Chemistry.
[4] C. Chiang,et al. Structures of Prostacyclin Synthase and Its Complexes with Substrate Analog and Inhibitor Reveal a Ligand-specific Heme Conformation Change* , 2008, Journal of Biological Chemistry.
[5] Rebecca C Wade,et al. Multiple, ligand-dependent routes from the active site of cytochrome P450 2C9. , 2012, Current drug metabolism.
[6] Danielson Pb,et al. The cytochrome P450 superfamily: biochemistry, evolution and drug metabolism in humans. , 2002 .
[7] J. Halpert,et al. Investigation by site‐directed mutagenesis of the role of cytochrome P450 2B4 non‐active‐site residues in protein–ligand interactions based on crystal structures of the ligand‐bound enzyme , 2012, The FEBS journal.
[8] Eric F. Johnson,et al. Determinants of Cytochrome P450 2C8 Substrate Binding , 2008, Journal of Biological Chemistry.
[9] Jose Cosme,et al. Crystal Structures of Human Cytochrome P450 3A4 Bound to Metyrapone and Progesterone , 2004, Science.
[10] K. Battaile,et al. Human Cytochrome P450 2E1 Structures with Fatty Acid Analogs Reveal a Previously Unobserved Binding Mode* , 2010, The Journal of Biological Chemistry.
[11] Virgil L. Woods,et al. Structural analysis of mammalian cytochrome P450 2B4 covalently bound to the mechanism-based inactivator tert-butylphenylacetylene: insight into partial enzymatic activity. , 2011, Biochemistry.
[12] Weiliang Zhu,et al. Possible Pathway(s) of Metyrapone Egress from the Active Site of Cytochrome P450 3A4: A Molecular Dynamics Simulation , 2007, Drug Metabolism and Disposition.
[13] Rebecca C Wade,et al. The ins and outs of cytochrome P450s. , 2007, Biochimica et biophysica acta.
[14] S. D. Black. Membrane topology of the mammalian P450 cytochromes , 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[15] S D Black,et al. Membrane topology of liver microsomal cytochrome P450 2B4 determined via monoclonal antibodies directed to the halt-transfer signal. , 1994, Biochemistry.
[16] James R. Halpert,et al. Structure of Microsomal Cytochrome P450 2B4 Complexed with the Antifungal Drug Bifonazole , 2006, Journal of Biological Chemistry.
[17] Sundarapandian Thangapandian,et al. Probing possible egress channels for multiple ligands in human CYP3A4: A molecular modeling study , 2010, Journal of molecular modeling.
[18] C. Stout,et al. Structural Basis of Drug Binding to CYP46A1, an Enzyme That Controls Cholesterol Turnover in the Brain* , 2010, The Journal of Biological Chemistry.
[19] M. Wilce,et al. The F-G loop region of cytochrome P450scc (CYP11A1) interacts with the phospholipid membrane. , 2003, Biochimica et biophysica acta.
[20] Mark S. P. Sansom,et al. Structure and Dynamics of the Membrane-Bound Cytochrome P450 2C9 , 2011, PLoS Comput. Biol..
[21] Karl-Heinz Ott,et al. Parametrization of GROMOS force field for oligosaccharides and assessment of efficiency of molecular dynamics simulations , 1996, J. Comput. Chem..
[22] Eric F. Johnson,et al. Structural Characterization of the Complex between α-Naphthoflavone and Human Cytochrome P450 1B1* , 2010, The Journal of Biological Chemistry.
[23] Frank E. Blaney,et al. Crystal Structure of Human Cytochrome P450 2D6* , 2005, Journal of Biological Chemistry.
[24] M. Karplus,et al. CHARMM: A program for macromolecular energy, minimization, and dynamics calculations , 1983 .
[25] E. Scott,et al. Nicotine and 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone Binding and Access Channel in Human Cytochrome P450 2A6 and 2A13 Enzymes* , 2012, The Journal of Biological Chemistry.
[26] W. Pryor. Cytochrome P450: Structure, mechanism, and biochemistry , 1996 .
[27] W. Pangborn,et al. Structural basis for androgen specificity and oestrogen synthesis in human aromatase , 2009, Nature.
[28] Eric F. Johnson,et al. The Structure of Human Cytochrome P450 2C9 Complexed with Flurbiprofen at 2.0-Å Resolution* , 2004, Journal of Biological Chemistry.
[29] F. Mackenzie,et al. Structural basis for pregnenolone biosynthesis by the mitochondrial monooxygenase system , 2011, Proceedings of the National Academy of Sciences.
[30] R C Wade,et al. How do substrates enter and products exit the buried active site of cytochrome P450cam? 2. Steered molecular dynamics and adiabatic mapping of substrate pathways. , 2000, Journal of molecular biology.
[31] C David Stout,et al. Structures of human microsomal cytochrome P450 2A6 complexed with coumarin and methoxsalen , 2005, Nature Structural &Molecular Biology.
[32] F. Guengerich,et al. Kinetics of Cytochrome P450 2E1-Catalyzed Oxidation of Ethanol to Acetic Acid via Acetaldehyde* , 1999, The Journal of Biological Chemistry.
[33] W. L. Jorgensen,et al. Development and Testing of the OPLS All-Atom Force Field on Conformational Energetics and Properties of Organic Liquids , 1996 .
[34] U. Singh,et al. A NEW FORCE FIELD FOR MOLECULAR MECHANICAL SIMULATION OF NUCLEIC ACIDS AND PROTEINS , 1984 .
[35] Rebecca C Wade,et al. Do mammalian cytochrome P450s show multiple ligand access pathways and ligand channelling? , 2005, EMBO reports.
[36] D E McRee,et al. Mammalian microsomal cytochrome P450 monooxygenase: structural adaptations for membrane binding and functional diversity. , 2000, Molecular cell.
[37] Sugunadevi Sakkiah,et al. Molecular modeling study on orphan human protein CYP4A22 for identification of potential ligand binding site. , 2010, Journal of molecular graphics & modelling.
[38] Karel Berka,et al. Membrane Position of Ibuprofen Agrees with Suggested Access Path Entrance to Cytochrome P450 2C9 Active Site , 2011, The journal of physical chemistry. A.
[39] M. Machius,et al. Pivotal role of water in the mechanism of P450BM-3. , 2001, Biochemistry.
[40] C David Stout,et al. Structure of mammalian cytochrome P450 2C5 complexed with diclofenac at 2.1 A resolution: evidence for an induced fit model of substrate binding. , 2003, Biochemistry.
[41] Weihua Li,et al. POSSIBLE PATHWAY(S) OF TESTOSTERONE EGRESS FROM THE ACTIVE SITE OF CYTOCHROME P450 2B1: A STEERED MOLECULAR DYNAMICS SIMULATION , 2005, Drug Metabolism and Disposition.
[42] S. Sligar,et al. Structural differences between soluble and membrane bound cytochrome P450s. , 2012, Journal of inorganic biochemistry.
[43] J. Halpert,et al. Crystal structures of cytochrome P450 2B4 in complex with the inhibitor 1-biphenyl-4-methyl-1H-imidazole: ligand-induced structural response through alpha-helical repositioning. , 2009, Biochemistry.
[44] E. Scott,et al. CYTOCHROME P450 17A1 STRUCTURES WITH PROSTATE CANCER DRUGS ABIRATERONE AND TOK-001 , 2011, Nature.
[45] E. Scott,et al. Key Residues Controlling Phenacetin Metabolism by Human Cytochrome P450 2A Enzymes , 2008, Drug Metabolism and Disposition.
[46] C David Stout,et al. Structure of Human Microsomal Cytochrome P450 2C8 , 2004, Journal of Biological Chemistry.
[47] Feixiong Cheng,et al. Investigation of Indazole Unbinding Pathways in CYP2E1 by Molecular Dynamics Simulations , 2012, PloS one.
[48] B. K. Muralidhara,et al. Structural and thermodynamic consequences of 1-(4-chlorophenyl)imidazole binding to cytochrome P450 2B4. , 2007, Biochemistry.
[49] James R. Halpert,et al. An open conformation of mammalian cytochrome P450 2B4 at 1.6-Å resolution , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[50] T. Poulos,et al. Structure and mechanism of the complex between cytochrome P4503A4 and ritonavir , 2010, Proceedings of the National Academy of Sciences.
[51] E. Scott,et al. Structures of Human Cytochrome P-450 2E1 , 2008, Journal of Biological Chemistry.
[52] Eric F. Johnson,et al. Crystal Structure of Human Cytochrome P450 2D6 with Prinomastat Bound* , 2012, The Journal of Biological Chemistry.
[53] Virgil L. Woods,et al. Plasticity of Cytochrome P450 2B4 as Investigated by Hydrogen-Deuterium Exchange Mass Spectrometry and X-ray Crystallography* , 2010, The Journal of Biological Chemistry.
[54] J. Halpert,et al. Structures of Cytochrome P450 2B6 Bound to 4-Benzylpyridine and 4-(4-Nitrobenzyl)pyridine: Insight into Inhibitor Binding and Rearrangement of Active Site Side Chains , 2011, Molecular Pharmacology.
[55] R. Wade,et al. How do substrates enter and products exit the buried active site of cytochrome P450cam? 1. Random expulsion molecular dynamics investigation of ligand access channels and mechanisms. , 2000, Journal of molecular biology.
[56] Ruth Nussinov,et al. Theoretical Characterization of Substrate Access/Exit Channels in the Human Cytochrome P450 3A4 Enzyme: Involvement of Phenylalanine Residues in the Gating Mechanism , 2009, The journal of physical chemistry. B.
[57] Weihua Li,et al. Exploring coumarin egress channels in human cytochrome p450 2a6 by random acceleration and steered molecular dynamics simulations , 2011, Proteins.
[58] Michal Otyepka,et al. Flexibility of human cytochromes P450: molecular dynamics reveals differences between CYPs 3A4, 2C9, and 2A6, which correlate with their substrate preferences. , 2008, The journal of physical chemistry. B.
[59] T. Poulos,et al. Interaction of human cytochrome P4503A4 with ritonavir analogs. , 2012, Archives of biochemistry and biophysics.
[60] Tao Zhang,et al. Long-Range Effects of a Peripheral Mutation on the Enzymatic Activity of Cytochrome P450 1A2 , 2011, J. Chem. Inf. Model..
[61] Karel Berka,et al. Dynamics and hydration of the active sites of mammalian cytochromes P450 probed by molecular dynamics simulations. , 2012, Current drug metabolism.
[62] Stephanie C Huelga,et al. Crystal Structure of a Cytochrome P450 2B6 Genetic Variant in Complex with the Inhibitor 4-(4-Chlorophenyl)imidazole at 2.0-Å Resolution , 2010, Molecular Pharmacology.
[63] Eric F. Johnson,et al. Structural insight into the altered substrate specificity of human cytochrome P450 2A6 mutants. , 2007, Archives of biochemistry and biophysics.
[64] K. Battaile,et al. Structural comparison of cytochromes P450 2A6, 2A13, and 2E1 with pilocarpine , 2012, The FEBS journal.
[65] T. Strassner,et al. Modeling of Selforganizing Systems , 1997 .
[66] Xiaodong Zhang,et al. Synthetic inhibitors of cytochrome P-450 2A6: inhibitory activity, difference spectra, mechanism of inhibition, and protein cocrystallization. , 2006, Journal of medicinal chemistry.
[67] M Ingelman-Sundberg,et al. Genetic susceptibility to adverse effects of drugs and environmental toxicants. The role of the CYP family of enzymes. , 2001, Mutation research.
[68] Jaroslav Koca,et al. CAVER: a new tool to explore routes from protein clefts, pockets and cavities , 2006, BMC Bioinformatics.
[69] Eric F. Johnson,et al. The Structure of Human Microsomal Cytochrome P450 3A4 Determined by X-ray Crystallography to 2.05-Å Resolution* , 2004, Journal of Biological Chemistry.
[70] Jose Cosme,et al. Crystal structure of human cytochrome P450 2C9 with bound warfarin , 2003, Nature.
[71] C. Jarzynski. Nonequilibrium Equality for Free Energy Differences , 1996, cond-mat/9610209.
[72] K. Palczewski,et al. Structural Basis for Three-step Sequential Catalysis by the Cholesterol Side Chain Cleavage Enzyme CYP11A1* , 2010, The Journal of Biological Chemistry.
[73] T. Sjögren,et al. Structural basis for ligand promiscuity in cytochrome P450 3A4 , 2006, Proceedings of the National Academy of Sciences.
[74] Eric F. Johnson,et al. Crystal structures of substrate-bound and substrate-free cytochrome P450 46A1, the principal cholesterol hydroxylase in the brain , 2008, Proceedings of the National Academy of Sciences.
[75] P. Kollman,et al. A Second Generation Force Field for the Simulation of Proteins, Nucleic Acids, and Organic Molecules , 1995 .
[76] C. Stout,et al. Structure of the Human Lung Cytochrome P450 2A13* , 2007, Journal of Biological Chemistry.
[77] Eric F. Johnson,et al. Structure of Mammalian Cytochrome P450 2B4 Complexed with 4-(4-Chlorophenyl)imidazole at 1.9-Å Resolution , 2004, Journal of Biological Chemistry.
[78] Eric F. Johnson,et al. Crystal structure of CYP24A1, a mitochondrial cytochrome P450 involved in vitamin D metabolism. , 2010, Journal of molecular biology.
[79] Alexander Zawaira,et al. On the deduction and analysis of singlet and two-state gating-models from the static structures of mammalian CYP450. , 2011, Journal of structural biology.